Acorda Therapeutics | ACOR - Selling And Administration Expenses


Acorda Therapeutics reported $21.82M in Selling and Administration Expenses for its fiscal quarter ending in June of 2023.



Selling And Administration Expenses Change Date
Acadia Pharmaceuticals USD 146.73M 21.82M Dec/2025
Agios Pharmaceuticals USD 42.97M 1.7M Dec/2025
ALKERMES USD 187.2M 15.43M Dec/2025
Alterity Therapeutics Limited AUD 1.45M 703.96K Dec/2025
Amgen USD 1.94B 237M Dec/2025
Anika Therapeutics USD 10.01M 14K Dec/2025
Arrowhead Research USD 46.02M 8.84M Dec/2025
Biogen USD 545.2M 38.6M Sep/2025
BioMarin Pharmaceutical USD 322.21M 98.79M Dec/2025
Cara Therapeutics USD 2.19M 2.45M Sep/2025
Cipla INR 13.25B 101.8M Dec/2025
Clal Biotechnology ILS 3.31M 513K Dec/2022
Compugen USD 2.21M 120K Dec/2025
CSL USD 1.23B 498M Dec/2025
Cytokinetics USD 91.72M 67.02M Dec/2025
Enanta Pharmaceuticals USD -1.05 0.31 Dec/2024
Gilead Sciences USD 1.78B 425M Dec/2025
GlaxoSmithKline GBP 2.68B 518M Dec/2025
Grifols EUR 320.45M 12.65M Dec/2025
Halozyme Therapeutics USD 64.64M 27.11M Dec/2025
Heron Therapeutics USD 23.74M 605K Dec/2025
Insmed USD 212.48M 26.11M Dec/2025
Ligand Pharmaceuticals USD 28.45M 8.27M Sep/2025
MannKind USD 29.09M 2.53M Sep/2025
Merck EUR 1.6B 136M Dec/2025
Moderna USD 308M 40M Dec/2025
Neurocrine Biosciences USD 301.8M 10.2M Dec/2025
Novartis USD 3.44B 128M Dec/2025
Pfizer USD 4.08B 894M Dec/2025
Sanofi EUR 2.75B 455M Dec/2025
Teva Pharmaceutical Industries USD 1.12B 147M Dec/2025
Ultragenyx Pharmaceutical USD 89M 2.38M Dec/2025
Vertex Pharmaceuticals USD 487M 41.9M Dec/2025